Markets

AI Spending Surge, Geopolitical Tensions and Monsoon Woes Converge on India’s Economy

AI Notice: Content is aggregated and summarized using Artificial Intelligence. Details may contain inaccuracies. Please verify facts independently before making financial or investment decisions.

U.S. tech giants are investing heavily in artificial‑intelligence infrastructure, with Alphabet’s capital expenditure for the April‑June quarter reaching $44.9 billion and a revised annual forecast of $195‑$205 billion. The spending spree fuels a broader AI build‑out that includes data centres, power plants, chip fabs and energy projects, keeping the race against China intense.

India is not left out of this AI super‑cycle. E2E Networks has emerged as a direct beneficiary, while banks such as Goldman Sachs and JPMorgan Chase in the U.S. have also profited from AI‑driven financing. The data‑centre boom is spilling over into India, where capex recovery is partly driven by data‑centre construction, global captive sites and a push toward green energy.

Steel, cement and power firms are riding the wave. The government’s focus on infrastructure has helped companies like UltraTech Cement and JSW Steel post strong Q1 results. However, the core industry index shows modest growth once iron ore is excluded, indicating uneven gains.

The IT services sector is the most vulnerable. Infosys delivered a weak Q1 and trimmed the upper end of its revenue growth guidance, reflecting a broader slowdown. Job creation has stalled, aggravating youth unemployment and sparking student protests. The government must prioritize jobs in its PLI 2.0 scheme to unlock the demographic dividend.

Geopolitical tensions are adding further strain. The Iran conflict has reignited, closing the Strait of Hormuz and driving Brent crude above $100 a barrel. Freight rates have surged, and airlines like IndiGo have felt the impact in Q1. The auto industry faces a bumpy road, but companies are countering headwinds with premiumisation and export growth, especially Bajaj Auto.

Tariff wars loom, with the U.S. threatening duties on generic drug imports from August 2028. This uncertainty could hurt Indian pharma firms such as Dr Reddy’s. At home, an erratic monsoon has rattled rural consumption, as highlighted by a NBSR survey.

The India Flash Purchasing Managers Composite Index for July fell to 54.3 from 57.1 in June, signalling the weakest private‑sector expansion since early 2022. Markets are walking a tightrope; a single misstep could swing sentiment from optimism to dread.

Investors should stay cautious, balancing conviction with stop‑losses, as the economy navigates this mix of opportunity and uncertainty.